Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis

被引:0
|
作者
Baradwan, Saeed [1 ]
AlJaroudi, Dania [2 ]
Agdi, Mohammed [3 ]
Hafedh, Bandr [1 ]
Abduljabbar, Hanin Hassan [1 ]
Sabban, Hussein [1 ,4 ]
Alzawawi, Nabigah [1 ]
Alsaad, Nasser [5 ]
Alshahrani, Majed Saeed [6 ]
Idriss, Abdullah [7 ]
AlSghan, Rayan [8 ]
Asiri, Muhammad [9 ]
Baradwan, Afnan [10 ]
Edrees, Alaa [11 ]
Abu-Zaid, Ahmed [12 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynecol, Jeddah, Saudi Arabia
[2] King Fahad Med City, Dept Reprod Endocrine & Infertil Med, Riyadh Hlth Cluster 2, Riyadh, Saudi Arabia
[3] Sahafa Hosp, Dept Reprod Endocrinol & Infertil, Dr Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia
[4] King Abdulaziz Univ, Fac Med Rabigh, Dept Obstet & Gynecol, Jeddah, Saudi Arabia
[5] Prince Sultan Mil Med City, Dept Reprod Endocrine & Infertil Med, Nucl Med Unit, Riyadh, Saudi Arabia
[6] Najran Univ, Fac Med, Dept Obstet & Gynecol, Najran, Saudi Arabia
[7] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Jeddah, Saudi Arabia
[8] Matern & Children Hosp, Dept Obstet & Gynecol, AlKharj, Saudi Arabia
[9] Abha Matern & Children Hosp, Dept Obstet & Gynecol, Abha, Saudi Arabia
[10] Al Salama Hosp, Dept Obstet & Gynecol, Jeddah, Saudi Arabia
[11] King Faisal Specialist Hosp & Res Ctr, Dept Res, Jeddah, Saudi Arabia
[12] Alfaisal Univ, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia
关键词
Ovarian hyperstimulation syndrome; Calcium; Cabergoline; Assisted reproductive technology; Meta-analysis; ENDOTHELIAL GROWTH-FACTOR; INFUSION; PHOSPHORYLATION; CLASSIFICATION; ANGIOGENESIS; RISK; OHSS;
D O I
10.1016/j.ejogrb.2024.07.054
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To conduct the first-ever systematic review and meta-analysis evaluating calcium infusion versus cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) among high-risk women undergoing assisted reproductive technology. Methods: Six databases were screened from inception until April 1, 2024. The included randomized and nonrandomized controlled studies were assessed for quality. The endpoints included the severity of OHSS and selected pregnancy-related outcomes. Endpoints were summarized as risk ratios (RRs) and 95% confidence intervals (CIs) in a random-effects model. Results: Six studies were analyzed, including 1687 patients (828 in the calcium group and 859 in the cabergoline group). The quality of the studies varied and reflected low risk and high risk of bias in two and four studies, respectively, according to the revised Cochrane risk of bias tool. No significant differences were noted between both groups regarding the rates of overall (n n = 5, RR = 0.65,95% CI [0.39, 1.07], p = 0.09), mild (n n = 4, RR = 1.05,95% CI [0.59, 1.89], p = 0.86), moderate (n n = 5, RR = 0.41,95% CI [0.15, 1.08], p = 0.07), and severe (n n = 6, RR = 0.36, 95 % CI [0.11, 1.22], p = 0.1) cases of OHSS. Leave-one-out sensitivity analysis of an outlier study revealed that calcium significantly reduced the occurrence of severe OHSS compared with cabergoline (n n = 5, RR = 0.16, 95 % CI [0.09, 0.43], p < 0.001, Higgins I-2 = 0 %). No significant differences were observed between both groups regarding the rates of clinical pregnancy (n n = 4, RR = 0.97, 95 % CI [0.88, 1.07], p = 0.57), ongoing pregnancy, live birth, and spontaneous abortion (Higgins I-2 < 50 % for all). Conclusion: Both agents yielded similar pregnancy-related outcomes. However, calcium infusion could potentially be more effective than cabergoline in reducing the rate of severe OHSS. Additional high-quality and well- controlled trials are essential to draw firm conclusions.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials
    Leitao, Valeria M. S.
    Moroni, Rafael M.
    Seko, Ludimila M. D.
    Nastri, Carolina O.
    Martins, Wellington P.
    [J]. FERTILITY AND STERILITY, 2014, 101 (03) : 664 - +
  • [2] Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study
    Fouda, Usama M.
    Elshaer, Hesham S.
    Youssef, Gamal G.
    Hanafy, Amal
    Mehrem, Waleed M.
    Youssef, Mohamed A.
    Farouk, Mona
    Nabil, Hala
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (01) : 122 - 126
  • [3] Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: A randomized clinical trial
    Elnory, Mohamed Anwar
    Elmantwe, Ashraf Nassif Mahmoud
    [J]. MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2018, 23 (04) : 357 - 362
  • [4] The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
    Hosseini, Marzieh Agha
    Aleyasin, Ashraf
    Mahdavi, Atossa
    Nezami, Romina
    Safdarian, Leila
    Fallahi, Parvin
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2011, 36 (03) : 207 - 212
  • [5] CABERGOLINE IN PREVENTION AND TREATMENT OF OVARIAN HYPERSTIMULATION SYNDROME
    Dosedla, Erik
    Gasparova, Petra
    Ballova, Zuzana
    Sitas, Martina
    Turcsanyiova, Zuzana
    Calda, Pavel
    [J]. AKTUALNI GYNEKOLOGIE A PORODNICTVI, 2023, 15 : 49 - 54
  • [6] Use of cabergoline for the ovarian hyperstimulation syndrome prevention
    Merino, V. Verdu
    Gonzalez-Villafanez, V.
    Alarcon, M.
    Lopez, L.
    Lopez-Yanez, L.
    de Segura, R. Gomez
    Arenas, J. M. Bajo
    [J]. HUMAN REPRODUCTION, 2007, 22 : I146 - I147
  • [7] Cabergoline versus calcium gluconate infusion in the prevention of ovarian hyperstimulation syndrome. A randomized controlled trial
    El-Shaer, H.
    Fouda, U.
    Youssef, G.
    Hanafy, A.
    Nabil, H.
    Mehrem, W.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 74 - 74
  • [8] Cabergoline as treatment of ovarian hyperstimulation syndrome: a review
    Kalampokas, Theodoros
    Creatsas, George
    Kalampokas, Emmanouil
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 98 - 100
  • [9] Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis
    Jun-Liang Guo
    Duo-Duo Zhang
    Yue Zhao
    Dan Zhang
    Xi-Meng Zhang
    Can-Quan Zhou
    Shu-Zhong Yao
    [J]. Scientific Reports, 6
  • [10] Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis
    Guo, Jun-Liang
    Zhang, Duo-Duo
    Zhao, Yue
    Zhang, Dan
    Zhang, Xi-Meng
    Zhou, Can-Quan
    Yao, Shu-Zhong
    [J]. SCIENTIFIC REPORTS, 2016, 6